BCRP1 and ovarian cancer: A side population of cells expressing NANOG, OCT4 and ABCG2/BCRP1 was isolated from ovarian cancer cell lines and ascites of ovarian cancer patients, and was found to have increased tumourgenicity and chemoresistance [47].